San Francisco, CA, United States of America

Catalin Sebastian Zonte

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Gilead Sciences, Inc.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Catalin Sebastian Zonte. Retrieved from https://idiyas.com/inventor/catalin-sebastian-zonte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Catalin Sebastian Zonte

Introduction

Catalin Sebastian Zonte is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of antiviral compounds, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Zonte holds a patent related to antiviral compounds. This invention encompasses anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of these compounds. Additionally, it covers processes and intermediates useful for preparing such compounds. He has 1 patent to his name.

Career Highlights

Catalin Zonte is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His work focuses on developing innovative solutions to combat viral infections, contributing to the company's mission of improving patient outcomes.

Collaborations

Zonte collaborates with talented professionals in his field, including Choung U Kim and Salman Y Jabri. Their combined expertise fosters a productive environment for research and development.

Conclusion

Catalin Sebastian Zonte's contributions to antiviral research and his innovative spirit exemplify the impact of dedicated inventors in the medical field. His work continues to pave the way for advancements in therapeutic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…